{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:02:52Z","timestamp":1790136172415,"version":"4.0.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40121-025-01283-3","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T07:38:50Z","timestamp":1766216330000},"page":"417-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Cefazolin Inoculum Effect: An Underappreciated Factor in MSSA Treatment Strategies"],"prefix":"10.1007","volume":"15","author":[{"given":"Prakhar","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Morrisette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew David","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo Lorenzo","family":"Ventresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Brassell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyuba","family":"Benin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4019-2679","authenticated-orcid":false,"given":"Razieh","family":"Kebriaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"1283_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13054-017-1801-3","volume":"21","author":"A Hassoun","year":"2017","unstructured":"Hassoun A, Linden PK, Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations\u2014a review of recent developments in MRSA management and treatment. Crit Care. 2017;21:211.","journal-title":"Crit Care"},{"key":"1283_CR2","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1093\/eurheartj\/ehz175","volume":"40","author":"L Liesenborghs","year":"2019","unstructured":"Liesenborghs L, Meyers S, Lox M, Criel M, Claes J, Peetermans M, et\u00a0al. Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves. Eur Heart J. 2019;40:3248\u201359.","journal-title":"Eur Heart J"},{"key":"1283_CR3","unstructured":"Two-dose therapy for S. aureus bloodstream infections on par with standard treatment | National Institutes of Health (NIH). https:\/\/www.nih.gov\/news-events\/news-releases\/two-dose-therapy-s-aureus-bloodstream-infections-par-standard-treatment. Retrieved 4 September 2025."},{"key":"1283_CR4","unstructured":"CDC. 2025. Antimicrobial resistance threats in the United States, 2021\u20132022. Antimicrobial resistance. https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/update-2022.html. Retrieved 17 July 2025."},{"key":"1283_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.micpath.2015.03.013","volume":"81","author":"AA Imani Fooladi","year":"2015","unstructured":"Imani Fooladi AA, Ashrafi E, Tazandareh SG, Koosha RZ, Rad HS, Amin M, et\u00a0al. The distribution of pathogenic and toxigenic genes among MRSA and MSSA clinical isolates. Microb Pathog. 2015;81:60\u20136.","journal-title":"Microb Pathog"},{"key":"1283_CR6","doi-asserted-by":"publisher","first-page":"300060521105887","DOI":"10.1177\/03000605211058872","volume":"49","author":"T Aratani","year":"2021","unstructured":"Aratani T, Tsukamoto H, Higashi T, Kodawara T, Yano R, Hida Y, et\u00a0al. Association of methicillin resistance with mortality of hospital-acquired Staphylococcus aureus bacteremia. J Int Med Res. 2021;49:3000605211058872.","journal-title":"J Int Med Res"},{"key":"1283_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","volume":"68","author":"AP Kourtis","year":"2019","unstructured":"Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, et\u00a0al. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections\u2014United States. MMWR Morb Mortal Wkly Rep. 2019;68:214\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1283_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jmii.2023.07.010","volume":"56","author":"S-H Kim","year":"2023","unstructured":"Kim S-H, Jeon M, Jang S, Mun SJ. Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: the importance of treatment response rather than bacteremia duration. J Microbiol Immunol Infect. 2023;56:1007\u201315.","journal-title":"J Microbiol Immunol Infect"},{"key":"1283_CR9","doi-asserted-by":"publisher","first-page":"E352","DOI":"10.9778\/cmajo.20140018","volume":"2","author":"RV Anantha","year":"2014","unstructured":"Anantha RV, Jegatheswaran J, Pepe DL, Priestap F, Delport J, Haeryfar SMM, et\u00a0al. Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study. CMAJ Open. 2014;2:E352\u20139.","journal-title":"CMAJ Open"},{"key":"1283_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/cid\/ciu301","volume":"59","author":"I Youngster","year":"2014","unstructured":"Youngster I, Shenoy ES, Hooper DC, Nelson SB. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis. 2014;59:369\u201375.","journal-title":"Clin Infect Dis"},{"key":"1283_CR11","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1128\/AAC.04677-14","volume":"59","author":"SN Rao","year":"2015","unstructured":"Rao SN, Rhodes NJ, Lee BJ, Scheetz MH, Hanson AP, Segreti J, et\u00a0al. Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2015;59:5232\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/cid\/cix287","volume":"65","author":"JS McDanel","year":"2017","unstructured":"McDanel JS, Roghmann M-C, Perencevich EN, Ohl ME, Goto M, Livorsi DJ, et\u00a0al. Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study. Clin Infect Dis. 2017;65:100\u20136.","journal-title":"Clin Infect Dis"},{"key":"1283_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1128\/AAC.00700-07","volume":"52","author":"S-H Kim","year":"2008","unstructured":"Kim S-H, Kim K-H, Kim H-B, Kim N-J, Kim E-C, Oh M, et\u00a0al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2008;52:192\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106363","volume":"58","author":"S Agnello","year":"2021","unstructured":"Agnello S, Wardlow LC, Reed E, Smith JM, Coe K, Day SR. Clinical outcomes of daptomycin versus anti-staphylococcal beta-lactams in definitive treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections. Int J Antimicrob Agents. 2021;58:106363.","journal-title":"Int J Antimicrob Agents"},{"key":"1283_CR15","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1093\/jac\/dky259","volume":"73","author":"MR Bidell","year":"2018","unstructured":"Bidell MR, Patel N, O\u2019Donnell JN. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. J Antimicrob Chemother. 2018;73:2643\u201351.","journal-title":"J Antimicrob Chemother"},{"key":"1283_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cmi.2019.03.010","volume":"25","author":"S Weis","year":"2019","unstructured":"Weis S, Kesselmeier M, Davis JS, Morris AM, Lee S, Scherag A, et\u00a0al. Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2019;25:818\u201327.","journal-title":"Clin Microbiol Infect"},{"key":"1283_CR17","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s15010-023-02168-8","volume":"52","author":"K Schmidt-Hellerau","year":"2024","unstructured":"Schmidt-Hellerau K, Breuninger M, Kessel J, Vehreschild MJGT, Paul G, Reusch J, et\u00a0al. Flucloxacillin and cefazolin for treatment of Staphylococcus aureus bloodstream infection. Infection. 2024;52:1159\u201363.","journal-title":"Infection"},{"key":"1283_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/asmcr.00114-24","volume":"1","author":"AA Smelter","year":"2025","unstructured":"Smelter AA, Frei CR, Smelter DF. Successful clearance of persistent Staphylococcus aureus pneumonia with high-dose continuous infusion cefazolin. ASM Case Reports. 2025;1:e00114-24.","journal-title":"ASM Case Reports"},{"key":"1283_CR19","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/jac\/dkaf065","volume":"80","author":"SO Lee","year":"2025","unstructured":"Lee SO, Lee S, Park S, Lee JE, Lee SH. In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin. J Antimicrob Chemother. 2025;80:1287\u201390.","journal-title":"J Antimicrob Chemother"},{"key":"1283_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.02495-21","volume":"60","author":"TC Dingle","year":"2022","unstructured":"Dingle TC, Gamage D, Gomez-Villegas S, Hanson BM, Reyes J, Abbott A, et\u00a0al. Prevalence and characterization of the cefazolin inoculum effect in North American methicillin-susceptible Staphylococcus aureus isolates. J Clin Microbiol. 2022;60:e02495-21.","journal-title":"J Clin Microbiol"},{"key":"1283_CR21","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1128\/AAC.00317-09","volume":"53","author":"EC Nannini","year":"2009","unstructured":"Nannini EC, Stryjewski ME, Singh KV, Bourgogne A, Rude TH, Corey GR, et\u00a0al. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother. 2009;53:3437\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2022.09.021","volume":"53","author":"A Bourreau","year":"2023","unstructured":"Bourreau A, Le Mabecque V, Broquet A, Caillon J. Prevalence of a cefazolin inoculum effect associated with blaZ gene types, and clinical outcomes among methicillin-susceptible Staphylococcus aureus blood isolates of patients with infective endocarditis. Infectious Diseases Now. 2023;53:104626.","journal-title":"Infectious Diseases Now"},{"key":"1283_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae069","volume":"6","author":"CK-F Lo","year":"2024","unstructured":"Lo CK-F, Sritharan A, Zhang J, Li N, Zhang C, Wang F, et\u00a0al. Clinical significance of cefazolin inoculum effect in serious MSSA infections: a systematic review. JAC-Antimicrobial Resistance. 2024;6:dlae069.","journal-title":"JAC-Antimicrobial Resistance"},{"key":"1283_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00703-20","volume":"64","author":"JC McNeil","year":"2020","unstructured":"McNeil JC, Sommer LM, Boyle M, Hogan P, Vallejo JG, Hult\u00e9n KG, et\u00a0al. Cefazolin inoculum effect and methicillin-susceptible Staphylococcus aureus osteoarticular infections in children. Antimicrob Agents Chemother. 2020;64:e00703-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy123","volume":"5","author":"WR Miller","year":"2018","unstructured":"Miller WR, Seas C, Carvajal LP, Diaz L, Echeverri AM, Ferro C, et\u00a0al. The cefazolin inoculum effect is associated with increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia. Open Forum Infect Dis. 2018;5:ofy123.","journal-title":"Open Forum Infect Dis"},{"key":"1283_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00382-18","volume":"62","author":"SK Wang","year":"2018","unstructured":"Wang SK, Gilchrist A, Loukitcheva A, Plotkin BJ, Sigar IM, Gross AE, et\u00a0al. Prevalence of a cefazolin inoculum effect associated with blaZ gene types among methicillin-susceptible Staphylococcus aureus isolates from four major medical centers in Chicago. Antimicrob Agents Chemother. 2018;62:e00382-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR27","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1093\/jac\/dkt254","volume":"68","author":"S Rincon","year":"2013","unstructured":"Rincon S, Reyes J, Carvajal LP, Rojas N, Cortes F, Panesso D, et\u00a0al. Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals. J Antimicrob Chemother. 2013;68:2773\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"1283_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02511-19","volume":"64","author":"LP Carvajal","year":"2020","unstructured":"Carvajal LP, Rincon S, Echeverri AM, Porras J, Rios R, Ordo\u00f1ez KM, et\u00a0al. Novel insights into the classification of staphylococcal \u03b2-lactamases in relation to the cefazolin inoculum effect. Antimicrob Agents Chemother. 2020;64:e02511-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00898-24","volume":"68","author":"LP Carvajal","year":"2024","unstructured":"Carvajal LP, Rincon S, Gomez Villegas SI, Matiz-Gonzalez JM, Ordo\u00f1ez K, Santamaria A, et\u00a0al. Prevalence of the cefazolin inoculum effect (CzIE) in nasal colonizing methicillin-susceptible Staphylococcus aureus in patients from intensive care units in Colombia and use of a modified rapid nitrocefin test for detection. Antimicrob Agents Chemother. 2024;68:e00898-24.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.51353","volume":"7","author":"B Jean","year":"2024","unstructured":"Jean B, Crolle M, Pollani C, Le Guilloux A, Martin-Blondel G, Tattevin P, et\u00a0al. \u03b2-lactam inoculum effect in methicillin-susceptible Staphylococcus aureus infective endocarditis. JAMA Netw Open. 2024;7:e2451353.","journal-title":"JAMA Netw Open"},{"key":"1283_CR31","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/jac\/dkaf115","volume":"80","author":"T Tala-Ighil","year":"2025","unstructured":"Tala-Ighil T, Royer G, Lepeule R, Fihman V, Galy A, Lim P, et\u00a0al. Clinical features and medical\u2013surgical management overweight the inoculum effect and genotypic characteristics of MSSA in infective endocarditis. J Antimicrob Chemother. 2025;80:1647\u201355.","journal-title":"J Antimicrob Chemother"},{"key":"1283_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116399","volume":"110","author":"S Tsuji","year":"2024","unstructured":"Tsuji S, Gotoh K, Manabe T, Iio K, Fukushima S, Matsushita O, et\u00a0al. Cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus clinical isolates. Diagn Microbiol Infect Dis. 2024;110:116399.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1283_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jiac.2017.10.021","volume":"24","author":"M Saeki","year":"2018","unstructured":"Saeki M, Shinagawa M, Yakuwa Y, Nirasawa S, Sato Y, Yanagihara N, et\u00a0al. Inoculum effect of high concentrations of methicillin-susceptible Staphylococcus aureus on the efficacy of cefazolin and other beta-lactams. J Infect Chemother. 2018;24:212\u20135.","journal-title":"J Infect Chemother"},{"key":"1283_CR34","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/jac\/dkaf093","volume":"80","author":"SI Gomez-Villegas","year":"2025","unstructured":"Gomez-Villegas SI, Rincon S, Carvajal LP, Matiz-Gonz\u00e1lez JM, Panesso D, Tran TT, et\u00a0al. Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America. J Antimicrob Chemother. 2025;80:1437\u201344.","journal-title":"J Antimicrob Chemother"},{"key":"1283_CR35","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 35th Edition. Clinical & Laboratory Standards Institute. Clinical & Laboratory Standards Institute. M100."},{"key":"1283_CR36","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1128\/AAC.00570-09","volume":"53","author":"K Kadlec","year":"2009","unstructured":"Kadlec K, Schwarz S. Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain. Antimicrob Agents Chemother. 2009;53:3589\u201391.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-1097(02)00896-0","volume":"215","author":"GJ Da Silva","year":"2002","unstructured":"Da Silva GJ, Correia M, Vital C, Ribeiro G, Sousa JC, Leit\u00e3o R, et\u00a0al. Molecular characterization of bla(IMP-5), a new integron-borne metallo-beta-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett. 2002;215:33\u20139.","journal-title":"FEMS Microbiol Lett"},{"key":"1283_CR38","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1126\/science.3107125","volume":"236","author":"O Herzberg","year":"1987","unstructured":"Herzberg O, Moult J. Bacterial resistance to \u03b2-lactam antibiotics: crystal structure of \u03b2-lactamase from Staphylococcus aureus PC1 at 2.5 \u00c5 resolution. Science. 1987;236:694\u2013701.","journal-title":"Science"},{"key":"1283_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/AAC.36.2.440","volume":"36","author":"DJ Zygmunt","year":"1992","unstructured":"Zygmunt DJ, Stratton CW, Kernodle DS. Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother. 1992;36:440\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/jac\/dki492","volume":"57","author":"JE Olsen","year":"2006","unstructured":"Olsen JE, Christensen H, Aarestrup FM. Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci. J Antimicrob Chemother. 2006;57:450\u201360.","journal-title":"J Antimicrob Chemother"},{"key":"1283_CR41","doi-asserted-by":"publisher","first-page":"13945","DOI":"10.1021\/ja044742u","volume":"126","author":"C Birck","year":"2004","unstructured":"Birck C, Cha JY, Cross J, Schulze-Briese C, Meroueh SO, Schlegel HB, et\u00a0al. X-ray crystal structure of the acylated \u03b2-lactam sensor domain of BlaR1 from Staphylococcus aureus and the mechanism of receptor activation for signal transduction. J Am Chem Soc. 2004;126:13945\u20137.","journal-title":"J Am Chem Soc"},{"key":"1283_CR42","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1046\/j.1365-2958.1997.4051770.x","volume":"24","author":"PD Gregory","year":"1997","unstructured":"Gregory PD, Lewis RA, Curnock SP, Dyke KGH. Studies of the repressor (BlaI) of \u03b2-lactamase synthesis in Staphylococcus aureus. Mol Microbiol. 1997;24:1025\u201337.","journal-title":"Mol Microbiol"},{"key":"1283_CR43","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/ofid\/ofaa417.027","volume":"7","author":"SI Gomez-Villegas","year":"2020","unstructured":"Gomez-Villegas SI, Dinh AQ, Reyes J, Panesso-Botero D, Reyes MI, Reyes MI, et\u00a0al. 28. Regulation of the staphylococcal \u03b2-lactamase plays a major role in the cefazolin inoculum effect. Open Forum Infect Dis. 2020;7:S14\u20135.","journal-title":"Open Forum Infect Dis"},{"key":"1283_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jac\/45.2.139","volume":"45","author":"RA Lewis","year":"2000","unstructured":"Lewis RA, Dyke KGH. MecI represses synthesis from the \u03b2-lactamase operon of Staphylococcus aureus. J Antimicrob Chemother. 2000;45:139\u201344.","journal-title":"J Antimicrob Chemother"},{"key":"1283_CR45","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/cbic.200500189","volume":"6","author":"I Wagner-D\u00f6bler","year":"2005","unstructured":"Wagner-D\u00f6bler I, Thiel V, Eberl L, Allgaier M, Bodor A, Meyer S, et\u00a0al. Discovery of complex mixtures of novel long-chain quorum sensing signals in free-living and host-associated marine Alphaproteobacteria. ChemBioChem. 2005;6:2195\u2013206.","journal-title":"ChemBioChem"},{"key":"1283_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","volume":"21","author":"EM Darby","year":"2023","unstructured":"Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, et\u00a0al. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2023;21:280\u201395.","journal-title":"Nat Rev Microbiol"},{"key":"1283_CR47","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41579-019-0186-5","volume":"17","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee S, Bassler BL. Bacterial quorum sensing in complex and dynamically changing environments. Nat Rev Microbiol. 2019;17:371\u201382.","journal-title":"Nat Rev Microbiol"},{"key":"1283_CR48","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3947\/ic.2019.51.4.376","volume":"51","author":"SO Lee","year":"2019","unstructured":"Lee SO, Lee S, Park S, Lee JE, Lee SH. The cefazolin inoculum effect and the presence of type A blaZ gene according to agr genotype in methicillin-susceptible Staphylococcus aureus bacteremia. Infect Chemother. 2019;51:376.","journal-title":"Infect Chemother"},{"key":"1283_CR49","doi-asserted-by":"publisher","first-page":"14036","DOI":"10.1073\/pnas.1509251112","volume":"112","author":"RK Gupta","year":"2015","unstructured":"Gupta RK, Luong TT, Lee CY. RNAIII of the Staphylococcus aureus agr system activates global regulator MgrA by stabilizing mRNA. Proc Natl Acad Sci USA. 2015;112:14036\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1283_CR50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2015.07.011","volume":"83","author":"YM Wi","year":"2015","unstructured":"Wi YM, Park YK, Moon C, Ryu SY, Lee H, Ki HK, et\u00a0al. The cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus blood isolates: their association with dysfunctional accessory gene regulator (agr). Diagn Microbiol Infect Dis. 2015;83:286\u201391.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1283_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","volume":"358","author":"PS Stewart","year":"2001","unstructured":"Stewart PS, William CJ. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135\u20138.","journal-title":"Lancet"},{"key":"1283_CR52","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10096-014-2241-5","volume":"34","author":"YP Chong","year":"2015","unstructured":"Chong YP, Park S-J, Kim ES, Bang K-M, Kim M-N, Kim S-H, et\u00a0al. Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome. Eur J Clin Microbiol Infect Dis. 2015;34:349\u201355.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1283_CR53","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1128\/JB.188.7.2726-2729.2006","volume":"188","author":"E Maiques","year":"2006","unstructured":"Maiques E, \u00dabeda C, Campoy S, Salvador N, Lasa \u00cd, Novick RP, et\u00a0al. \u03b2-lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus. J Bacteriol. 2006;188:2726\u20139.","journal-title":"J Bacteriol"},{"key":"1283_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1128\/JB.01464-06","volume":"189","author":"RT Cirz","year":"2007","unstructured":"Cirz RT, Jones MB, Gingles NA, Minogue TD, Jarrahi B, Peterson SN, et\u00a0al. Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin. J Bacteriol. 2007;189:531\u20139.","journal-title":"J Bacteriol"},{"key":"1283_CR55","doi-asserted-by":"publisher","first-page":"037","DOI":"10.4103\/0974-2727.78563","volume":"3","author":"VK Vaidya","year":"2011","unstructured":"Vaidya VK. Horizontal transfer of antimicrobial resistance by extended-spectrum \u03b2 lactamase-producing Enterobacteriaceae. J Lab Physicians. 2011;3:037\u201342.","journal-title":"J Lab Physicians"},{"key":"1283_CR56","doi-asserted-by":"publisher","first-page":"e03163","DOI":"10.1128\/spectrum.03163-24","volume":"13","author":"VL Campod\u00f3nico","year":"2025","unstructured":"Campod\u00f3nico VL. Optimizing antibiotic use in MSSA bacteremia: a stewardship-focused approach. Microbiol Spectr. 2025;13:e03163-e3224.","journal-title":"Microbiol Spectr"},{"key":"1283_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01938-20","volume":"59","author":"S Rincon","year":"2021","unstructured":"Rincon S, Carvajal LP, Gomez-Villegas SI, Echeverri AM, Rios R, Dinh A, et\u00a0al. A test for the rapid detection of the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus. J Clin Microbiol. 2021;59:e01938-20.","journal-title":"J Clin Microbiol"},{"key":"1283_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.114926","volume":"96","author":"C Allen","year":"2020","unstructured":"Allen C, Turner C, Kalsi S, Jamieson D, Li Y, Morgan H, et\u00a0al. Development of a rapid phenotypic test on a microfluidic device for carbapenemase detection using the chromogenic compound nitrocefin. Diagn Microbiol Infect Dis. 2020;96:114926.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1283_CR59","doi-asserted-by":"publisher","first-page":"6886","DOI":"10.1002\/anie.201702776","volume":"56","author":"KE Boehle","year":"2017","unstructured":"Boehle KE, Gilliand J, Wheeldon CR, Holder A, Adkins JA, Geiss BJ, et\u00a0al. Utilizing paper-based devices for antimicrobial-resistant bacteria detection. Angew Chem Int Ed. 2017;56:6886\u201390.","journal-title":"Angew Chem Int Ed"},{"key":"1283_CR60","doi-asserted-by":"publisher","first-page":"9070","DOI":"10.1038\/s41467-024-53192-7","volume":"15","author":"J Lawrence","year":"2024","unstructured":"Lawrence J, O\u2019Hare D, Van Batenburg-Sherwood J, Sutton M, Holmes A, Rawson TM. Innovative approaches in phenotypic beta-lactamase detection for personalised infection management. Nat Commun. 2024;15:9070.","journal-title":"Nat Commun"},{"key":"1283_CR61","unstructured":"Nitrocef DisksTM. Hardy Diagnostics."},{"key":"1283_CR62","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/jac\/dkab032","volume":"76","author":"R Skov","year":"2021","unstructured":"Skov R, Lonsway DR, Larsen J, Larsen AR, Samulionien\u00e9 J, Limbago BM. Evaluation of methods for detection of \u03b2-lactamase production in MSSA. J Antimicrob Chemother. 2021;76:1487\u201394.","journal-title":"J Antimicrob Chemother"},{"key":"1283_CR63","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1128\/AAC.05473-11","volume":"56","author":"M Hagihara","year":"2012","unstructured":"Hagihara M, Wiskirchen DE, Kuti JL, Nicolau DP. In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2012;56:202\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR64","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1093\/jac\/dkaf122","volume":"80","author":"\u00c1 Rodr\u00edguez-Villodres","year":"2025","unstructured":"Rodr\u00edguez-Villodres \u00c1, Soto-Gallego C, Ortiz De La Rosa JM, Rodr\u00edguez-Rodr\u00edguez M, Casimiro-Soriguer CS, Gimeno-Gasc\u00f3n A, et\u00a0al. Impact of the inoculum effect on cefepime activity against AmpC-hyperproducing Enterobacter spp.: insights into resistance mechanisms. J Antimicrob Chemother. 2025;80:1687\u201393.","journal-title":"J Antimicrob Chemother"},{"key":"1283_CR65","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.3390\/s130405130","volume":"13","author":"B Gray","year":"2013","unstructured":"Gray B, Hall P, Gresham H. Targeting agr- and agr-like quorum sensing systems for development of common therapeutics to treat multiple gram-positive bacterial infections. Sensors. 2013;13:5130\u201366.","journal-title":"Sensors"},{"key":"1283_CR66","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/apm.13346","volume":"131","author":"TM Leegaard","year":"2023","unstructured":"Leegaard TM, Justesen US, Matuschek E, Giske CG, the NordicAST Study Group on Automated AST. Performance of automated antimicrobial susceptibility testing for the detection of antimicrobial resistance in gram\u2010negative bacteria: a NordicAST study. APMIS. 2023;131:543\u201351.","journal-title":"APMIS"},{"key":"1283_CR67","unstructured":"Tankeshwar A. 2015. Nitrocefin test: principle, procedure, uses \u2022 Microbe online. Microbe Online. https:\/\/microbeonline.com\/nitrocefin-test-principle-procedure-uses-limitations\/. Retrieved 10 September 2025."},{"key":"1283_CR68","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00213-21","volume":"59","author":"R Humphries","year":"2021","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the Clinical and Laboratory Standards Institute performance standards for antimicrobial susceptibility testing, M100, 31st edition. J Clin Microbiol. 2021;59:e00213-21.","journal-title":"J Clin Microbiol"},{"key":"1283_CR69","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cmi.2017.07.001","volume":"24","author":"S Lee","year":"2018","unstructured":"Lee S, Song K-H, Jung S-I, Park WB, Lee SH, Kim Y-S, et\u00a0al. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea. Clin Microbiol Infect. 2018;24:152\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"1283_CR70","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2180-12-104","volume":"12","author":"AJ McCarthy","year":"2012","unstructured":"McCarthy AJ, Lindsay JA. The distribution of plasmids that carry virulence and resistance genes in Staphylococcus aureus is lineage associated. BMC Microbiol. 2012;12:104.","journal-title":"BMC Microbiol"},{"key":"1283_CR71","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41579-020-00497-1","volume":"19","author":"J Rodr\u00edguez-Beltr\u00e1n","year":"2021","unstructured":"Rodr\u00edguez-Beltr\u00e1n J, DelaFuente J, Le\u00f3n-Sampedro R, MacLean RC, San Mill\u00e1n \u00c1. Beyond horizontal gene transfer: the role of plasmids in bacterial evolution. Nat Rev Microbiol. 2021;19:347\u201359.","journal-title":"Nat Rev Microbiol"},{"key":"1283_CR72","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00806-19","volume":"63","author":"R Bellouard","year":"2019","unstructured":"Bellouard R, Deschanvres C, Deslandes G, Dailly \u00c9, Asseray N, Jolliet P, et\u00a0al. Population pharmacokinetic study of cefazolin dosage adaptation in bacteremia and infective endocarditis based on a nomogram. Antimicrob Agents Chemother. 2019;63:e00806-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"1283_CR73","doi-asserted-by":"publisher","first-page":"19763","DOI":"10.1038\/s41598-021-99162-7","volume":"11","author":"J Lanoisel\u00e9e","year":"2021","unstructured":"Lanoisel\u00e9e J, Chaux R, Hodin S, Bourayou S, Gibert A, Philippot R, et\u00a0al. Population pharmacokinetic model of cefazolin in total hip arthroplasty. Sci Rep. 2021;11:19763.","journal-title":"Sci Rep"},{"key":"1283_CR74","unstructured":"Ottawa Hospital Research Institute. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Retrieved 17 September 2025."},{"key":"1283_CR75","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et\u00a0al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435\u201386.","journal-title":"Circulation"},{"key":"1283_CR76","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1186\/s12879-024-10171-z","volume":"24","author":"AM Kilani","year":"2024","unstructured":"Kilani AM, Alabi ED, Adeleke OE. Coexistence of the blaZ gene and selected virulence determinants in multidrug-resistant Staphylococcus aureus: insights from three Nigerian tertiary hospitals. BMC Infect Dis. 2024;24:1269.","journal-title":"BMC Infect Dis"},{"key":"1283_CR77","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/life15010049","volume":"15","author":"K Azeem","year":"2025","unstructured":"Azeem K, Fatima S, Ali A, Ubaid A, Husain FM, Abid M. Biochemistry of bacterial biofilm: insights into antibiotic resistance mechanisms and therapeutic intervention. Life. 2025;15:49.","journal-title":"Life"},{"key":"1283_CR78","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s42770-023-01243-4","volume":"55","author":"GD Rocha","year":"2024","unstructured":"Rocha GD, De Simoni Gouveia JJ, Da Costa MM, Soares RAN, Gouveia GV. Resistance and virulence in Staphylococcus aureus by whole-genome sequencing: a comparative approach in blaZ-positive isolates. Braz J Microbiol. 2024;55:955\u201367.","journal-title":"Braz J Microbiol"},{"key":"1283_CR79","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00284-023-03303-2","volume":"80","author":"I Singh","year":"2023","unstructured":"Singh I, Roshan M, Vats A, Behera M, Gautam D, Rajput S, et\u00a0al. Evaluation of virulence, antimicrobial resistance and biofilm forming potential of methicillin-resistant Staphylococcus aureus (MRSA) isolates from bovine suspected with mastitis. Curr Microbiol. 2023;80:198.","journal-title":"Curr Microbiol"},{"key":"1283_CR80","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1089\/mdr.2013.0229","volume":"20","author":"S Lee","year":"2014","unstructured":"Lee S, Kwon KT, Kim H-I, Chang HH, Lee J-M, Choe PG, et\u00a0al. Clinical implications of cefazolin inoculum effect and \u03b2-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia. Microb Drug Resist. 2014;20:568\u201374.","journal-title":"Microb Drug Resist"}],"updated-by":[{"DOI":"10.1007\/s40121-026-01347-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000}}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01283-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:03:47Z","timestamp":1776409427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01283-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01283-3","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: \u201cthe author\u2019s name Remo Lorenzo Ventresca was incorrectly written as Remi Lorenzo Ventresca.\u201d","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40121-026-01347-y","URL":"https:\/\/doi.org\/10.1007\/s40121-026-01347-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Taylor Morrisette is currently receiving grant funding through Stellus Rx and AbbVie Inc.; has participated in scientific advisory boards for AbbVie Inc. and Basilea Pharmaceutica; has provided expert witness testimony to Copeland, Stair Valz & Lovell, and Huff, Powell & Bailey; and has received honoraria from Infectious Diseases Special Edition and Managed Healthcare Executive. Razieh Kebriaei is supported by National Institutes of Health (NIH) grant no. R03AI183164-01. All other authors (Prakhar Srivastava, Elizabeth Singleton, Andrew David Berti, Remo Lorenzo Ventresca, Emily Brassell, and Lyuba Benin) have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is a review of previously published studies and does not involve any new experiments on humans or animals. Therefore, ethical approval and informed consent were not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}